Literature DB >> 199619

H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells.

R K Root, J A Metcalf.   

Abstract

Normal and cytochalasin B-treated human granulocytes have been studied to determine some of the interrelationships between phagocytosis-induced respiration and superoxide and hydrogen peroxide formation and release into the extracellular medium by intact cells. By using the scopoletin fluorescent assay to continuously monitor extracellular hydrogen peroxide concentrations during contact of cells with opsonized staphylococci, it was demonstrated that the superoxide scavengers ferricytochrome c and nitroblue tetrazolium significantly reduced the amount of H(2)O(2) released with time from normal cells but did not abolish it. This inhibitory effect was reversed by the simultaneous addition of superoxide dismutase (SOD), whereas the addition of SOD alone increased the amount of detectable H(2)O(2) in the medium. The addition of sodium azide markedly inhibited myeloperoxidase-H(2)O(2)-dependent protein iodination and more than doubled H(2)O(2) release, including the residual amount remaining after exposure of the cells to ferricytochrome c, suggesting its origin from an intracellular pool shared by several pathways for H(2)O(2) catabolism. When cells were pretreated with cytochalasin B and opsonized bacteria added, reduced oxygen consumption was observed, but this was in parallel to a reduction in specific binding of organisms to the cells when compared to normal. Under the influence of inhibited phagosome formation by cytochalasin B, the cells released an increased amount of superoxide and peroxide into the extracellular medium relative to oxygen consumption, and all detectable peroxide release could be inhibited by the addition of ferricytochrome c. Decreased H(2)O(2) production in the presence of this compound could not be ascribed to diminished bacterial binding, decreased oxidase activity, or increased H(2)O(2) catabolism and was reversed by the simultaneous addition of SOD. Furthermore, SOD and ferricytochrome c had similar effects on another H(2)O(2)-dependent reaction, protein iodination, in both normal and cytochalasin B cells. When oxygen consumption, O(2.) (-), and H(2)O(2) release were compared in the presence of azide under identical incubation conditions, the molar relationships for normal cells were 1.00:0.34:0.51 and for cytochalasin B-treated cells 1.00:0.99:0.40, respectively. Nonopsonized, or opsonized but disrupted, bacteria did not stimulate any of these metabolic functions. The results indicate that with normal cells approximately 50% of H(2)O(2) released during phagocytosis is derived directly from O(2.) (-) by dismutation, the remainder appearing from an (intra)cellular source shared by azide-inhibitable heme enzymes. With cytochalasin B treatment the evidence is consistent with the derivation of all H(2)O(2) from an O(2.) (-) precursor which is released from the cell surface. Furthermore, when activated by phagocytic particle binding, the neutrophil O(2.) (-) generating system appears to make more of this compound than can be accounted for by dismutation to H(2)O(2). This establishes conditions for the direct participation of both compounds in the microbicidal and cytocidal activity of these cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199619      PMCID: PMC372483          DOI: 10.1172/JCI108886

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme.

Authors:  E K Hodgson; I Fridovich
Journal:  Biochemistry       Date:  1975-12-02       Impact factor: 3.162

2.  Role of the superoxide anion in the myeloperoxidase-mediated antimicrobial system.

Authors:  S J Klebanoff
Journal:  J Biol Chem       Date:  1974-06-25       Impact factor: 5.157

Review 3.  Mechanism of phagocytosis-associated oxidative metabolism in polymorphonuclear leucocytes and macrophages.

Authors:  F Rossi; D Romeo; P Patriarca
Journal:  J Reticuloendothel Soc       Date:  1972-08

4.  The role of the phagocyte in host-parasite interactions. 13. The direct quantitative estimation of H2O2 in phagocytizing cells.

Authors:  B Paul; A J Sbarra
Journal:  Biochim Biophys Acta       Date:  1968-02-01

5.  Receptors for human gamma G globulin on human neutrophils.

Authors:  R P Messner; J Jelinek
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

6.  Quantitative leukocyte iodination.

Authors:  S H Pincus; S J Klebanoff
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

7.  Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies.

Authors:  R L Baehner; N Gilman; M L Karnovsky
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

8.  Superoxide dismutases of Escherichia coli: intracellular localization and functions.

Authors:  E M Gregory; F J Yost; I Fridovich
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

9.  Singlet excited oxygen as a mediator of the antibacterial action of leukocytes.

Authors:  N I Krinsky
Journal:  Science       Date:  1974-10-25       Impact factor: 47.728

10.  Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors.

Authors:  R K Root; T P Stossel
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  100 in total

1.  A new assay to monitor the degranulation process in phagocytizing human neutrophils.

Authors:  Violetta Borelli; Maria Giovanna Perrotta; Francesca Vita; Maria Rosa Soranzo; Giuliano Zabucchi
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

2.  Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies.

Authors:  M T Keogan; V L Esnault; A J Green; C M Lockwood; D L Brown
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 3.  [Biochemistry of cellular radiation reactions. An indication for ongoing protective mechanisms against oxidative cell damage].

Authors:  K Günther
Journal:  Naturwissenschaften       Date:  1990-09

4.  Poly L-histidine. A potent stimulator of superoxide generation in human blood leukocytes.

Authors:  I Ginsburg; R Borinski; M Sadovnic; Y Eilam; K Rainsford
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

5.  Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techniques.

Authors:  B E Britigan; D J Hassett; G M Rosen; D R Hamill; M S Cohen
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

6.  Outer membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils.

Authors:  N Okamura; J K Spitznagel
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

8.  Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes.

Authors:  P A Leong; M S Cohen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Interactions between antibiotics and human neutrophils in the killing of staphylococci.

Authors:  R K Root; R Isturiz; A Molavi; J A Metcalf; H L Malech
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: implications for pathogenesis of chronic inflammation.

Authors:  P A Leong; J H Schwab; M S Cohen
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.